Anticipate generic drug launch
Proactively manage your pharmacy inventory
Find generic entry opportunities
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Drug patents …
… from Kazakhstan to Kalamazoo
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Abstract:||Benzene derivatives of the formula: ##SPC1## Wherein R.sup.1 represents alkanoylamino of not more than nine carbon atoms, R.sup.2 represents alkyl of one through six carbon atoms, and R.sup.3 represents alkyl of one through six carbon atoms or cycloalkyl of three through six carbon atoms, possess pharmacodynamic properties and are useful in the treatment of various cardiac disorders. Moreover, they can be used as starting materials for corresponding compounds in which the ketone group --COR.sup.2 is replaced by a grouping ##SPC2## Wherein R.sup.4 represents, for example, a hydroxy group, or an optionally substituted ureido or thioureido group, which possess similar pharmacodynamic properties.|
|Inventor(s):||Wooldridge; Kenneth Robert Harry (Brentwood, EN), Basil; Berkeley (Highwood, Near Chelmsford, EN)|
|Assignee:||May & Baker Limited (Dagenham, Essex, EN)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||286262||<disabled in preview>|
|Austria||286963||<disabled in preview>|
|Austria||289826||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.